Marc Rudoltz is a qualified professional, that works in Windmil Therapeutics on the position of Interim Chief Medical Officer since 2018. This person has earned professional experience in more than 16 positions at various companies. Marc Rudoltz went to the University of Pennsylvania School of Medicine and got education from 1994 to 1996. Town Center, New Jersey is the city, where this professional was known to be located. The person's email address and phone number can be easily accessed through this website on demand.
Name variants:
Mark Rudoltz
Last updated Apr 21, 2024
Contact Information
Last Update
Jul 9, 2022
Location
Town Center, NJ
Company
Windmil Therapeutics
Workplace
Interim Chief Medical Officer
Work History
Interim Chief Medical Officer
WindMIL Therapeutics is a privately funded biotechnology company developing marrow infiltrating lymphocytes (MILs[TM]) for the treatment of hematologic malignancies and solid tumors. I was ...
Apr 2018 — Sep 2018
Interim Chief Medical Officer
215 1St St, Cambridge, MA 02142
Apr 2017 — Oct 2017
Member and Investor
MABA is an angel investor group focused exclusively on new and emerging life science companies. Membership is by invitation only. Due diligence activities are performed by group members, foc...
from Sep 2017
Researcher and Invention Commercialization Specialist
from Jan 2015
Clinical Consultant
45 Sidney St, Cambridge, MA 02139
Blueprint Medicines was a privately funded company when I was first hired in late 2014, when I was the only physician in the company. After the hiring of a full-time CMO I transitioned into...
from Dec 2014
Chief Medical Officer
200 Smith St, Waltham, MA 02451
As Chief Medical Officer of Deciphera Pharmaceuticals LLC, I catalyzed the transformation of the company from a research-focused to a full-fledged clinical stage biotechnology firm, includin...
Sep 2013 — Jun 2014
President
Provide expert medical consulting services to the biotechnology, pharmaceutical, medical device, and finance industries. Locum tenens radiation oncologist.
from Jan 2013
Chief Medical Officer
4505 Emperor Blvd SUITE 300, Durham, NC 27703
Leadership in global clinical development overseeing oncology and infectious disease programs.
Oct 2011 — Dec 2012
Senior Global Clinical Leader
Led hematology indications for clinical development for Glivec and for pediatric and clinical pharmacology programs for both Glivec and Tasigna. Provided clinical expertise for business deve...
Jan 2007 — Oct 2010
Adjunct Assistant Professor - Radiation Oncology
180 Somerset St, New Brunswick, NJ 08901
from Aug 2006
Instructor, Department of Radiation Oncology
3451 Walnut St, Philadelphia, PA 19104
Jun 1994 — Apr 1997
Education
1994 — 1996
1990 — 1994
1989 — 1990
1981 — 1985
Occupations
Executive
Chairperson
Surgeon-General
Scientist
Biotechnology Professional
Doctor
Oncologist
Chief Executive
Health Services Director
Health Services Manager
Biologist
Biological Scientist
Medical Practice Professional
Medical Practitioner
Skills
Oncology
Clinical Development
Clinical Trials
Pharmaceutical Industry
Biotechnology
Infectious Diseases
Cancer
Clinical Research
Pharmaceutics
Cro
Medical Writing
Medical Affairs
Medical Devices
Hematology
Drug Development
Clinical Pharmacology
Therapeutic Areas
Healthcare
Gcp
Small Molecules
Radiopharmaceuticals
Pharmacovigilance
Ctms
Immunology
Pediatrics
Lifesciences
FAQs about Marc Rudoltz
What's the main profession of Marc Rudoltz?
This professional's job is President
What jobs is Marc Rudoltz a professional at?
Marc Rudoltz is proficient at Executive and Chairperson jobs.
Where does Marc Rudoltz currently live?
Marc Rudoltz lives in Town Center, New Jersey.
How many companies did Marc Rudoltz work at?
Marc Rudoltz worked at 16 jobs.
Where has Marc Rudoltz studied?
Marc studied at the University of Pennsylvania School of Medicine from 1994 to 1996.
What is professional industry that Marc Rudoltz is connected to?
This person works in Biotechnology industry.
What are professional skills of Marc Rudoltz?
This person has skills in the following areas: Oncology, Clinical Development, Clinical Trials, Pharmaceutical Industry, Biotechnology, Infectious Diseases, Cancer, Clinical Research, Pharmaceutics, and Cro.